DMSO, New Hope for Arthritis?: Hearing Before the Select Committee on Aging, House of Representatives, Ninety-sixth Congress, Second Session, March 24, 1980

Capa
U.S. Government Printing Office, 1980 - 180 páginas
 

Páginas seleccionadas

Outras edições - Ver tudo

Palavras e frases frequentes

Passagens conhecidas

Página 67 - As used in this subsection and subsection (e), the term "substantial evidence" means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended,...
Página 1 - COMMITTEE ON AGRICULTURE, Washington, DC. The subcommittee met, pursuant to notice, at 10 am, in room 1302, Longworth House Office Building, Hon.
Página 165 - Foreign Commerce, House of Representatives, Washington, DC DEAR SIR : I would like to take this opportunity on behalf of the American Medical Association to submi.t for your consideration our views concerning HR 7700.
Página 23 - I am convinced that topical application of DMSO in the treatment of acute musculoskeletal conditions, is a striking and significant therapeutic contribution. During the ten months I conducted clinical investigation with this medication, I practically discarded physical therapy as treatment for acute musculoskeletal problems, because the rehabilitation of my patients was so prompt. There was little or no necessity to prescribe narcotics and tranquilizers, since pain was promptly mitigated following...
Página 2 - Good morning, ladies and gentlemen. I would like to welcome you to the hearing of the Subcommittee on Housing and Consumer Interests of the House Select Committee on Aging.
Página 57 - ... such studies. (d) The Commissioner may approve proposed clinical studies involving the administration of dimethylsulfoxide (DMSO) preparations to man provided that all of the following conditions are met: (1) The proposed study restricts the use of dimethylsulfoxide (DMSO) to cutaneous application in serious conditions, such as scleroderma, persistent herpes zoster, and severe rheumatoid arthritis, for which no satisfactory therapy is now available.
Página 9 - Thank you, Mr. Chairman. The CHAIRMAN. Mr. Hopkins. Mr. HOPKINS. Thank you, Mr. Chairman.
Página 57 - Thank you very much, Mr. Chairman. We are pleased to be here today to discuss...
Página 11 - Mr. Chairman, I have a statement I would like to submit for the record, but I would prefer to talk off the cuff about these pertinent problems.
Página 23 - Dimethyl sulfoxide is a useful adjunct in the treatment of rheumatoid arthritis, degenerative arthritis and gouty arthritis. It primarily will relieve pain, but will also reduce inflammation and increase joint mobility. Due to its effectiveness in the treatment of arthritis, Americans by the thousands are flocking to nations such as Mexico to receive DMSO. In Mexico they are charged seven to eight hundred dollars for three days of treatment. One entrepreneur in this "South of the Border" country...

Informação bibliográfica